CPC Subgroup
C12Y 116/01 with NAD+ or NADP+ as acceptor (1.16.1)
Full Title
Oxidoreductases oxidizing metal ions (1.16) > with NAD+ or NADP+ as acceptor (1.16.1)
9 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 116/01001 Mercury(II) reductase (1.16.1.1)
- C12Y 116/01002 Diferric-transferrin reductase (1.16.1.2)
- C12Y 116/01003 Aquacobalamin reductase (1.16.1.3)
- C12Y 116/01004 Cob(II)alamin reductase (1.16.1.4)
- C12Y 116/01005 Aquacobalamin reductase (NADPH) (1.16.1.5)
- C12Y 116/01006 Cyanocobalamin reductase (cyanide-eliminating) (1.16.1.6)
- C12Y 116/01007 Ferric-chelate reductase (NADH) (1.16.1.7)
- C12Y 116/01008 [Methionine synthase] reductase (1.16.1.8)
- C12Y 116/01009 Ferric-chelate reductase (NADPH) (1.16.1.9)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692